Skip to main content

Table 2 Gastrointestinal symptoms and scores of the UCLA GIT 2.0 and its subscales in all visits, N = 940

From: Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

 

n

%

 

Heartburn

323

(35.2)

 

Regurgitation

123

(13.4)

 

Dysphagia

184

(20.1)

 

Early satiety

106

(11.6)

 

Vomiting

34

(3.7)

 

Upper abdomen pain

26

(2.8)

 

Bloating

157

(17.1)

 

Diarrhea

84

(9.2)

 

Constipation

109

(11.9)

 

Fecal incontinence

58

(6.3)

 

UCLA GIT 2.0 subscales

Median

Q1, Q3

Range

Reflux

0.25

0.00, 0.63

(0–3)

Distention/bloating

0.50

0.00, 1.00

(0–3)

Fecal soilage

0.00

0.00, 0.00

(0–3)

Diarrhea

0.00

0.00, 0.50

(0–2)

Social functioning

0.00

0.00, 0.33

(0–2.5)

Emotional wellbeing

0.00

0.00, 0.22

(0–3)

Constipation

0.00

0.00, 0.50

(0–2.5)

Total score of UCLA GIT 2.0

0.22

0.07, 0.49

(0–2.4)